Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02110069
Title A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Children's Hospital Medical Center, Cincinnati, Pfizer

Vincristine Sulfate


Age Groups: child | adult
Covered Countries USA

No variant requirements are available.